Igniting regional momentum in pharma manufacturing
Arab Pharma Manufacturers’ Expo 2025 marks a transformative edition in Amman, Jordan, with record participation, breakthrough technologies, and cross-border partnerships.
The 7th Arab Pharma Manufacturers’ Expo 2025 concluded with exceptional success, igniting new momentum for pharmaceutical manufacturing across the Arab world.
Held at the Jordan International Exhibition Center (JIEC) on July 8 and 9, 2025, the Exhibition brought together the largest-ever gathering of industry leaders, innovators, and government authorities from the region, marking a decisive leap forward for pharma sector development.
With the participation of over 214 exhibitors from 18 countries, the exhibition floor buzzed with energy and collaboration. Thousands of visitors explored next-generation pharma manufacturing solutions from automated processing and packaging technologies to analytical instrumentation, cleanroom innovations, APIs, and complete turnkey solutions.
The event welcomed 2,245+ professional buyers and decision-makers, including pharmaceutical manufacturers, distributors, importers, health regulators, procurement heads, and policy influencers. Delegations from Egypt, Saudi Arabia, Syria, Lebanon, Tunisia, Iraq, Algeria, and Jordan underscored the pan-Arab significance of the platform.
The exhibition was officially inaugurated by Dr.Firas Al-Hawari, Minister of Health – Jordan, in the presence of key dignitaries and industry champions, including:
- Hammoudi Abbas – Advisor to the Prime Minister for Pharmaceutical Industry, Iraq
- AbdoMahalli – Assistant Minister of Health for Drug Affairs, Syria
- Tamer Al-Hussami – Vice Chairman, Egyptian Drug Authority
- Abdul Rahman Al-Mutairi – Chairman, National Committee for Pharmaceutical Industries, Saudi Arabia
- Gamal El-Leithy – Head, Pharmaceutical Industry Chamber, Egypt
In addition to several other high-ranking representatives from Lebanon, Tunisia, and Jordan.
Parallel to the expo, the ARAB PHARMA CONFERENCE themed “Pharma Contract Manufacturing: Opportunities and Innovations” attracted more than 250 delegates, making it the largest pharma-focused knowledge platform in the region. Discussions centred on regulatory harmonization, quality control, innovation pipelines, and strategic manufacturing partnerships across Arab nations.
Tabuk Pharmaceuticals, Jordan joined as the Diamond Sponsor, while Safa Pharmaceuticals, Iraq supported as Silver Sponsor, lending further credibility to the event’s stature.
Organized jointly by the Arab Union of the Manufacturers of Pharmaceuticals and Medical Appliances (AUPAM) and GPE EXPO PVT LTD, the event also received support from national industry associations such as:
- The Tunisia Association of Generic Medicines
- Iraqi League of Medicine Producers
- Jordanian Association of Pharmaceutical Manufacturers
- Syrian Scientific Council for National Pharmaceutical Industries
- Syndicate of Pharmaceutical Industries in Lebanon
With unmatched networking, meaningful knowledge-sharing, and tangible business leads, the 7th edition of the Arab Pharma Manufacturers’ Expo 2025 has set a new benchmark for what’s possible in the regional pharma industry.
The countdown now begins for the 2026 edition, expected to be even larger and more transformative. For more details, visit: www.ArabPharmaExpo.com or email [email protected].
Arab Pharmaceutical Manufacturing Sector
The Arab pharmaceutical manufacturing industry is undergoing a period of significant growth and strategic transformation. With a collective market value exceeding USD 30 billion in 2025 and projected to reach USD 42 billion by 2030, the sector is driven by a shared regional ambition to strengthen self-sufficiency, enhance production capacity, and reduce dependence on imports.
This momentum is supported by expanding healthcare needs, increasing public and private investments, and focused government initiatives aimed at boosting local production, particularly in generics, biotechnology, and value-added pharmaceutical segments.
Jordan continues to lead the region as a centre of pharmaceutical excellence. With a mature industrial base, a skilled workforce, and strong regulatory compliance aligned with international GMP standards, Jordan exports to more than 60 countries and remains a trusted supplier across the Middle East, Africa, and parts of Europe.
The country’s industry is marked by its ability to adapt to new technologies and regulations while maintaining high standards in quality and safety. This has reinforced Jordan’s position as a vital contributor to regional pharmaceutical resilience and innovation.
Across the broader Arab region, manufacturing capabilities are expanding in countries such as Egypt, Saudi Arabia, Iraq, and the UAE. Governments are increasingly prioritizing pharmaceutical industrialization as a national objective, integrating it with healthcare security, economic diversification, and job creation. Contract manufacturing is gaining traction as local and international firms seek flexible, cost-effective production solutions. Biopharmaceuticals, APIs, and high-tech formulations are becoming key areas of focus, alongside strategic regulatory reforms to improve market access and expedite licensing.
The Arab Pharma Manufacturers’ Expo 2025 reflects these industry trends and the collective aspiration of Arab nations to establish a robust, interconnected pharmaceutical ecosystem. The event served as a platform for fostering cross-border collaborations, technology transfer, and regulatory harmonization – driving the region toward a future of innovation, accessibility, and industrial strength in pharmaceutical manufacturing.
